This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Health Care Stocks to Watch

NEW YORK ( TheStreet) -- DepoMed (DEPO), Neoprobe (NEOP), Invacare (IVC - Get Report), and Integra LifeSciences Holdings (IART - Get Report) are among 10 health care stocks expected to report robust quarterly earnings, according to analysts polled by Bloomberg. Moreover, these stocks have upsides ranging from 3%-64%.

10. Almost Family (AFAM - Get Report) is a provider of home health services. The company has two operating segments: Visiting Nurse (VN) and Personal Care (PC). The Company is compensated for its services by Medicare (Visiting Nurse only), Medicaid, other third party payers (insurance companies) and private pay (paid by personal funds).

The company is expected to report its first quarter 2011 results on Apr. 28. Total revenue is forecast to increase 4.1% to $85.2 million from $81.8 million in the year-ago quarter. Net income is seen at $6.2 million or 67 cents per share, as compared to $7.4 million or 80 cents per share reported in the first quarter of 2010.

During March, the company acquired the assets of the Medicare-certified home health agency owned by Caregivers Health Network Inc. The terms of the transaction were not disclosed. However, the agency generated approximately $5 million in revenue in their last fiscal year.

Of the eight analysts covering the stock, 25% recommend it a buy, while the remaining rate it a hold. There are no sell ratings on the stock. On average, analysts expect an upside of 3% to $37.25 in value from current levels. Moreover, analysts at Zacks Investment Research upgraded the stock to neutral from underperform, while analysts at Collins Stewart initiated coverage with a hold rating and a price target of $38.

1 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AFAM $36.17 3.10%
ABAX $40.07 0.60%
BABY $34.91 2.50%
CNMD $37.39 2.30%
IVC $14.78 1.70%


Chart of I:DJI
DOW 16,090.33 +75.95 0.47%
S&P 500 1,872.28 +20.07 1.08%
NASDAQ 4,343.6070 +74.8440 1.75%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs